Selective Estrogen Receptor Modulators (SERMs) undoubtedly are a cornerstone of pharmaceutical PCT interventions. They functionality as aggressive inhibitors at estrogen receptors within the hypothalamus even though exhibiting tissue-selective agonist or antagonist Attributes throughout the human body. SERMs are essential in regulating post cycle e